marginally significantp = 0.06
No polymorphism showed association with bladder cancer risk at the 5% significance level, although individuals carrying the 280His variant allele had a marginally significant increased risk of bladder TCC compared to those carrying the homozygote wildtype genotype (adjusted OR [95% CI], 1.50 [0.98–2.28], p = 0.06).